FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns a pharmaceutical composition possessing antihypoxic properties, improving coronary and cerebral circulation, improving cognitive functions, having antioxidant, antiischemic and hypolipidemic action, ...
Traditionally, the development of a new solid dosage form is formulation-driven and less focus is put on the design of a specific microstructure for the dr... D Markl,A Strobel,R Schlossnikl,... - 《International Journal of Pharmaceutics》 被引量: 0发表: 2018年 Design, preparation and ph...
<div p-id="p-0001">The invention relates to a pharmaceutical composition and oral dosage forms comprising a bisphosphonate in combination with an enhancer to enhance intestinal delivery of the bisphos
International Journal of Pharmaceutics 24; 173-184 (1985). Geere G et al. Plasma androgens after a single oral dose of testosterone undecanoate. Archives of Disease in Childhood 55; 218-220 (1980). Frey H et al. Bioavailability of oral testosterone in males. Eur. Clin. Pharmacol. 16; ...
Which in turn leads to yield a robust formulation with advantages of economics in terms of time, money and development efforts (Singh et al., 2013). Moreover, it is worthy to convert conventional liquid SNEDDS to a solid dosage form (solid SNEDDS) having high stability, better transport...
The oral drug administration is the most preferred route of drug delivery due to convenience, patient adherence and rational production investment of oral solid dosage forms. After oral ingestion, the drug must be liberated and then solubilized in gastrointestinal (GI) fluid before it can be absorbe...
6.SustainedandControlledReleaseDrugDeliverySystems,editedby JosephR.Robinson 7.ModernPharmaceutics,editedbyGilbertS.Banker andChristopherT.Rhodes 8.PrescriptionDrugsinShortSupply:CaseHistories,MichaelA.Schwartz 9.ActivatedCharcoal:AntidotalandOtherMedicalUses,DavidO.Cooney 10.ConceptsinDrugMetabolism(intwoparts),...
The application of chimeric antigen receptor (CAR) T cells in the management of hematological malignancies has emerged as a noteworthy therapeutic breakthrough. Nevertheless, the utilization and effectiveness of CAR-T cell therapy in solid tumors are sti
(QTPP) should be defined for the final or intermediate product. This QTPP should include all desired characteristics such as the dosage form, drug load, particle size, bioavailability, dissolution behavior, taste and stability (230). Based on the QTPP the next step will be the definition of ...
Pharmaceutics2023,15(5), 1448;https://doi.org/10.3390/pharmaceutics15051448 Submission received: 20 February 2023/Revised: 5 May 2023/Accepted: 8 May 2023/Published: 10 May 2023 (This article belongs to the Special IssueRecent Advances in Solid Dosage Form) ...